Low-dose naltrexone for fibromyalgia: a re-analysis suggests lower efficacy than previously reported
Open Access
- 1 January 2026
- journal article
- Published by Korean Pain Society in The Korean Journal of Pain
- Vol. 39 (1) , 140-143
Abstract
Karin Due Bruun, Maria Juul Nielsen, Henrik Bjarke Vaegter, Morten Rune Blichfeldt-Eckhardt, Kirstine Amris, and Julie Roenne Pedersen. Korean J Pain 2026;39:140-3. https://doi.org/10.3344/kjp.25275Keywords
This publication has 5 references indexed in Scilit:
- Efficacy and safety of low-dose naltrexone for the management of fibromyalgia: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysisThe Korean Journal of Pain, 2024
- Naltrexone 6 mg once daily versus placebo in women with fibromyalgia: a randomised, double-blind, placebo-controlled trialThe Lancet Rheumatology, 2023
- Low-dose naltrexone for treatment of pain in patients with fibromyalgia: a randomized, double-blind, placebo-controlled, crossover studyPain Reports, 2023
- Association of low-dose naltrexone and transcranial direct current stimulation in fibromyalgia: a randomized, double-blinded, parallel clinical trialBrazilian Journal of Anesthesiology (English Edition), 2022
- Low‐dose naltrexone for the treatment of fibromyalgia: Findings of a small, randomized, double‐blind, placebo‐controlled, counterbalanced, crossover trial assessing daily pain levelsArthritis & Rheumatism, 2013